通过RNA干扰克服Candida albicans中的抗真菌耐药性:一个治疗视角
Akshay Kisan Mundhe1, Reena Rajkumari1
1Department of Integrative Biology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Frontiers in cellular and infection microbiology
|December 8, 2025
概括
RNA干扰 (RNAi) 提供了一种有前途的新方法来对抗耐药Candida albicans感染. 这种基于RNA的基因沉默策略针对关键的真菌基因,可能克服对当前抗真菌药物的耐药性.
科学领域:
- 菌类学 菌类学是指菌类学.
- 分子生物学分子生物学
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 菌是医院获得感染的主要原因之一.
- 抗真菌耐药性是一个日益严重的全球健康问题,限制了治疗选择.
- 现有的疗法面临挑战,因为阻力机制,如排泄过度表达和ergosterol路径突变.
研究的目的:
- 探索RNA干扰 (RNAi) 作为对抗耐药Candida albicans的治疗策略的潜力.
- 审查已确立的抗真菌标和新兴的基于RNAi的基因沉默方法.
- 在C. albicans.中确定RNAi治疗的潜在分子标.
主要方法:
- 对Candida albicans抗真菌耐药性的当前文献的综述.
- 探索RNA干扰 (RNAi) 机制和在真菌病原体中的应用.
- 识别和讨论RNAi的潜在分子标,包括ERG1,ERG6,ERG11,CDR1,CDR2,CLB2和GC1.
主要成果:
- 在其他真菌病原体中,RNAi已经证明了有效性,但其在C. albicans中的应用是新兴的.
- 已经确定了C. albicans中RNAi的潜在分子标,包括参与ergosterol生物合成和药物耐药性的基因.
- RNAi可以在转录层面克服阻力,绕过翻译后阻力机制.
结论:
- RNA干扰为对抗抗性Candida albicans提供了一个新的治疗途径.
- 在siRNA设计,化学修饰和传递系统方面的进步对于基于RNAi的抗真菌疗法至关重要.
- 基于RNA的疗法有可能彻底改变对具有挑战性的真菌感染的治疗.
相关概念视频
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K
Types of RNA
72.4K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
72.4K
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Gene Regulation in Microbial Communities: Quorum Sensing
473
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
473


